Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ALBOMED is a German medical device company specializing in the development and manufacturing of high-quality viscoelastics for ophthalmic and orthopedic applications. Founded in 1997, the company is a leading producer of sodium hyaluronate-based products used to protect intraocular structures during cataract surgery and to provide viscosupplementation for patients with osteoarthritis. Their product portfolio includes the Pe-Ha-Luron and Pe-Ha-Visco lines for ophthalmology and the ViscoPlus range for joint therapy. ALBOMED operates state-of-the-art manufacturing facilities in Germany, adhering to international quality standards to serve a global market. The company focuses on "Made in Germany" quality, utilizing non-animal origin hyaluronic acid to ensure patient safety and product consistency.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ALBOMED.